GLP-1 medications (semaglutide, tirzepatide and others) commonly cause digestive side effects, especially early on and just after a dose increase. Most are mild and ease as the body adjusts, but a few are warning signs. This page is a plain-English overview of what’s commonly reported, how the timing usually goes, and when to contact a clinician. It is educational and physician-deferring — not medical advice.
Widely reported, and usually mildest at the start of each dose step:
Most digestive effects are worst in the first days after starting or after each dose increase, then settle as tolerance builds. Because the dose is raised gradually (titration), you may notice a brief return of nausea at each step. Everyone is different — some feel little, others more.
Logging side effects and dose changes over time makes patterns visible — useful for you and for your doctor. Pepathary lets you record symptoms alongside your dose schedule on your device.
They are typically worst in the first days after starting or after a dose increase, then ease over days to a few weeks as the body adjusts. Individual experiences vary.
A temporary return of nausea or digestive upset is common at each step up, which is why the dose is raised gradually. If it is severe or does not settle, talk to your prescriber.
Severe or persistent abdominal pain, relentless vomiting or dehydration, signs of a gallbladder or pancreas problem, or any severe allergic reaction. When in doubt, seek care.
Some people and prescribers slow the schedule for tolerability. That is a decision to make with your prescriber — never adjust the dose yourself.
A dated record of symptoms next to your dose changes helps you and your doctor see what is improving, what is not, and whether a step-up is the trigger.